These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ineffectiveness of dialysis in transthyretin (TTR) clearance in familial amyloid polyneuropathy type I, in spite of lower stability of the TTR Met30 variant. Beirão I; Lobato L; Riedstra S; Costa PM; Pimentel S; Guimarães S Clin Nephrol; 1999 Jan; 51(1):45-9. PubMed ID: 9988146 [TBL] [Abstract][Full Text] [Related]
3. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report]. Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265 [TBL] [Abstract][Full Text] [Related]
9. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis. Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585 [TBL] [Abstract][Full Text] [Related]
10. Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy. Lobato L; Beirão I; Silva M; Bravo F; Silvestre F; Guimarães S; Sousa A; Noël LH; Sequeiros J Nephrol Dial Transplant; 2003 Mar; 18(3):532-8. PubMed ID: 12584275 [TBL] [Abstract][Full Text] [Related]
11. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Coutinho MC; Cortez-Dias N; Cantinho G; Conceição I; Oliveira A; Bordalo e Sá A; Gonçalves S; Almeida AG; de Carvalho M; Diogo AN Circ Cardiovasc Imaging; 2013 Sep; 6(5):627-36. PubMed ID: 23833285 [TBL] [Abstract][Full Text] [Related]
12. Duration of end-stage renal disease and kidney transplant outcome. Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of familial amyloid polyneuropathy]. Adams D; Samuel D; Slama M Presse Med; 2012 Sep; 41(9 Pt 1):793-806. PubMed ID: 22341949 [TBL] [Abstract][Full Text] [Related]
14. End-stage renal disease in systemic amyloidosis: clinical course and outcome on dialysis. Martinez-Vea A; García C; Carreras M; Revert L; Oliver JA Am J Nephrol; 1990; 10(4):283-9. PubMed ID: 2240055 [TBL] [Abstract][Full Text] [Related]
15. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Wong CF; McCarthy M; Howse ML; Williams PS Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158 [TBL] [Abstract][Full Text] [Related]
16. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome. Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M; Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308 [TBL] [Abstract][Full Text] [Related]
17. Is lower urinary tract dysfunction an early marker of Portuguese type familial amyloidotic polyneuropathy in women? Preliminary results. Gomes MJ; Martins Silva A; Salinas Casado J; Castro Diaz D; Figueiredo A; Singla A; Rosier P; Silva C; Fuente Carvalho L; Rizk D Arch Esp Urol; 2014 Jul; 67(6):557-64. PubMed ID: 25048588 [TBL] [Abstract][Full Text] [Related]
18. End-stage renal failure due to transthyretin amyloidosis after liver transplantation: outcomes in 19 registry cases. Rocha A; Beirão I; Pessegueiro H; Almeida R; Lobato L Amyloid; 2017 Mar; 24(sup1):85-86. PubMed ID: 28434351 [No Abstract] [Full Text] [Related]
19. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings. Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367 [TBL] [Abstract][Full Text] [Related]